Murine models of human multiple myeloma (MM) are key tools for the study of disease biology as well as for investigation and selection of novel candidate therapeutics for clinical translation. In the last years, a variety of pre-clinical models have been generated to recapitulate a wide spectrum of biological features of MM. These systems range from spontaneous or transgenic models of murine MM, to subcutaneous or orthothopic xenografts of human MM cell lines in immune compromised animals, to platform allowing the engraftment of primary/bone marrowdependent MM cells within a human bone marrow milieu to fully recapitulate human disease. Selecting the right model for specific pre-clinical research is essential for the successful completion of investigation. We here review recent and most known pre-clinical murine, transgenic and humanized models of MM, focusing on major advantages and/or weaknesses in the light of different research aims.

Rossi M., Botta C., Arbitrio M., Grembiale R.D., Tagliaferri P., Tassone P. (2018). Mouse models of multiple myeloma: Technologic platforms and perspectives. ONCOTARGET, 9(28), 20119-20133 [10.18632/oncotarget.24614].

Mouse models of multiple myeloma: Technologic platforms and perspectives

Botta C.;
2018-01-01

Abstract

Murine models of human multiple myeloma (MM) are key tools for the study of disease biology as well as for investigation and selection of novel candidate therapeutics for clinical translation. In the last years, a variety of pre-clinical models have been generated to recapitulate a wide spectrum of biological features of MM. These systems range from spontaneous or transgenic models of murine MM, to subcutaneous or orthothopic xenografts of human MM cell lines in immune compromised animals, to platform allowing the engraftment of primary/bone marrowdependent MM cells within a human bone marrow milieu to fully recapitulate human disease. Selecting the right model for specific pre-clinical research is essential for the successful completion of investigation. We here review recent and most known pre-clinical murine, transgenic and humanized models of MM, focusing on major advantages and/or weaknesses in the light of different research aims.
2018
Rossi M., Botta C., Arbitrio M., Grembiale R.D., Tagliaferri P., Tassone P. (2018). Mouse models of multiple myeloma: Technologic platforms and perspectives. ONCOTARGET, 9(28), 20119-20133 [10.18632/oncotarget.24614].
File in questo prodotto:
File Dimensione Formato  
24614-344367-4-PB.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 2.86 MB
Formato Adobe PDF
2.86 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/513580
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 29
  • ???jsp.display-item.citation.isi??? ND
social impact